Lorem publishes commentary titled ‘Establishing a Commercial Solution for Extremely Rare Genetic Diseases’ in Nature Biotechnology.

'Defying Rare Disease' premieres Thursday at 7 p.m. ET Susannah Rosen was diagnosed with a KIF1A gene mutation at the age of 2½. Patients diagnosed with severe KIF1A gene mutations may live only into ...

SAN DIEGO and GENEVA, Jan. 13, 2026 /PRNewswire/ -- The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to n-Lorem's antisense ...

Representative Elise Stefanik announced her New York gubernatorial campaign early Friday, though she may not have let her team know. The Trump loyalist’s website was still plastered in “lorem ipsum” ...

This fall, Charlotte bartenders are blurring the lines between cocktails and culinary art in delicious ways, putting out drinks. with complex flavors and blending ingredients that you’ve never before ...

Stanley Crooke, Ionis Pharmaceuticals founder and n-Lorem founder, joins 'Squawk Box' to discuss the fight against rare diseases, the development of ASO technology, and more. Got a confidential news ...

AI-generated summary reviewed by our newsroom. Read our AI Policy. Cheers, Charlotte! The city now has the bragging rights of being home to one of the best bars in the country. Esquire dropped its ...

Target knew this year's Pride collection would be under the microscope. Still, the company made a glaring misstep: several self-identified employees have shared photos of a slip-up on the Pride ...

Spotify has all the world’s music… in theory. But its algorithms decide many things. Like other technology platforms, Spotify makes decisions to make more money. And this affects the music we listen ...

Five years ago, the n-Lorem Foundation set out on a mission to provide free, lifetime ASO treatments for nano-rare patients. Today, we've made remarkable strides forming a united nano-rare community ...